[1] Dickinson A J, Gausas R E. Orbital lymphatics: do they exist [J] .Eye(Lond),2006,20(10):1145-1148.
[2] Uno T, Isobe K, Shikama N, et al. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: A multiinstitutional, retrospective review of 50 patients[J]. Cancer,2003,98(4):865-871.
[3] Suh C O, Shim S J, Lee S W, et al. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior[J]. Int J Radiat Oncol Biol Phys, 2006,65(1):228-233.
[4] Yamashita H, Nakagawa K, Asari T, et al. Radiotherapy for 41 patients with stages I and II MALT lymphoma: A retrospective study[J]. Radiother Oncol, 2008,87(3):412-417.
[5] Nam H, Ahn Y C, Kim Y D, et al. Prognostic significance of anatomic subsites: Results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma[J]. Radiother Oncol,2009,90(2):236-241.
[6] Son S H, Choi B O, Kim G W, et al. Primary radiation therapy in patients with localized orbital marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) [J]. Int J Radiat Oncol Biol Phys, 2010,77(1):86-91.
[7] Fasola C E, Jones J C, Huang D D, et al. Low-dose radiation therapy (2Gy×2) in the treatment of orbital lymphoma[J]. Int J Radiat Oncol Biol Phys,2013,86(5):930-935.
[8] Ejima Y, Sasaki R, Okamoto Y, et al. Ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy[J]. Radiother Oncol,2006,78(1):6-9.
[9] Hata M, Omura M, Koike I, et al. Treatment effects and sequelae of radiation therapy for orbital mucosa-associated lymphoid tissue lymphoma[J]. Int J Radiat Oncol Biol Phys, 2011,81(5):1387-1393.
[10] Pfeffer M R, Rabin T, Tsvang L, et al. Orbital lymphoma: Is it necessary to treat the entire orbit[J]. Int J Radiat Oncol Biol Phys,2004,60(2):527-530.
[11] Goda J S, Le L W, Lapperriere N J, et al. Localized orbital mucosa-associated lymphoma tissue lymphoma managed with primary radiation therapy: efficacy and toxicity[J]. Int J Radiat Oncol Biol Phys,2011,81(4):e659-666.
[12] Le Q T, Eulau S M, George T I, et al. Primary radiotherapy for localized orbital MALT lymphoma[J]. Int J Radiat Oncol Biol Phys,2002,52(3): 657-663.
[13] Fung C Y, Tarbell N J, Lucarelli M J, et al. Ocular adnexal lymphoma: clinical behavior of distinct world health organization classification subtypes[J]. Int J Radiat Oncol Biol Phys,2003,57(5): 1382-1391.
[14] Hoskin P, Kirkwood A, Popova B, et al. Fort RT: A phase 3 multi-center prospective randomized trial of low dose radiation therapy for follicular and marginal zone lymphoma[J]. Int J Radiat Oncol Biol Phys,2013,85(1):22.
[15] Tsang R W, Gospodarowicz M K, Pintilie M, et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome[J]. J Clin Oncol,2003,21(22):4157-4164.
[16] Lee J L, Kim M K, Lee K H, et al. Extranodal marginal zone B-cell lymphomas of mucosa-associated lymphoid tissue-type of the orbit and ocular adnexa[J]. Ann Hematol,2005,84(1):13-18.
[17] Jung S K, Paik J S, Jung S E, et al. Suggestion of response evaluation criteria in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma (OAML) [J]. Ann Hematol ,2015,94(7):1185-1193.
[18] Hashimoto N, Sasaki R, Nishimura H, et al. Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy[J]. Int J Radiat Oncol Biol Phys,2012,82(5): 1509-1514.
[19] Ohja S, Nakamura K, Shioyama Y, et al. Treatment outcome of radiotherapy for localized primary ocular adnexal MALT lymphoma-prognostic effect of the AJCC Tumor-Node-Metastasis clinical staging system[J].Anticancer Res,2015,35(6):3591-3597.
[20] Hasegawa M, Kojima M, Shioya M, et al. Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathological review according to the WHO classification[J]. Int J Radiat Oncol Biol Phys, 2003,57(1):172-176.
[21] Aviles A, Neri N, Calva A, et al. Addition of a short course of chemotherapy did not improve outcome in patients with localized marginal B-cell lymphoma of the orbit[J]. Oncology,2006,70(3):173-176.
[22] Kaushik M, Pulido J S, Schild S E, et al. Risk of Radiation Retinopathy in Patients With Orbital and Ocular Lymphoma[J]. Int J Radiat Oncol Biol Phys,2012,84(5):1145-1150.